王春江, 杨灿熙, 任凌希, 刘韶, 蒋跃平. 九香虫水提取物中一对新颖Z/E异构化的吡啶季胺盐J. 药学学报, 2024, 59(1): 166-169. DOI: 10.16438/j.0513-4870.2023-0400
引用本文: 王春江, 杨灿熙, 任凌希, 刘韶, 蒋跃平. 九香虫水提取物中一对新颖Z/E异构化的吡啶季胺盐J. 药学学报, 2024, 59(1): 166-169. DOI: 10.16438/j.0513-4870.2023-0400
WANG Chun-jiang, YANG Can-xi, REN Ling-xi, LIU Shao, JIANG Yue-ping. An unprecedented pair of Z/E isomeric pyridinium compound from the aqueous extract of Aspongopus chinensis DallasJ. Acta Pharmaceutica Sinica, 2024, 59(1): 166-169. DOI: 10.16438/j.0513-4870.2023-0400
Citation: WANG Chun-jiang, YANG Can-xi, REN Ling-xi, LIU Shao, JIANG Yue-ping. An unprecedented pair of Z/E isomeric pyridinium compound from the aqueous extract of Aspongopus chinensis DallasJ. Acta Pharmaceutica Sinica, 2024, 59(1): 166-169. DOI: 10.16438/j.0513-4870.2023-0400

九香虫水提取物中一对新颖Z/E异构化的吡啶季胺盐

An unprecedented pair of Z/E isomeric pyridinium compound from the aqueous extract of Aspongopus chinensis Dallas

  • 摘要: 采用大孔吸附树脂、正相硅胶、反向半制备等色谱技术, 从中药九香虫水提取中分离得到一对Z/E异构化吡啶季胺盐新颖碳骨架类化合物。通过核磁共振、红外、质谱等多种光谱技术鉴定了两个新化合物12的结构分别为(Z)-3-(but-1″-en-1″-yl)-1-(2ʹ-hydroxyethyl)-4-propylpyridin-1-ium, 命名为aspongopyridine A和(E)-3-(but-1″-en-1″-yl)-1-(2ʹ-hydroxyethyl)-4-propylpyridin-1-ium, 命名为aspongopyridine B。此外, 还对化合物12的体外抗炎、抗肿瘤、乙酰胆碱酯酶抑制和丁酰胆碱酯酶抑制活性进行了评价, 结果表明化合物12有微弱的乙酰胆碱酯酶抑制活性。

     

    Abstract: A novel pair of Z/E isomeric compounds with unprecedented carbon skeleton were isolated from an aqueous extract of Aspongopus chinensis Dallas by macroporous resin, silica gel, and semi-preparative high performance liquid chromatography (HPLC). Their structures were identified by nuclear magnetic resonance (NMR), Infrared spectroscopy (IR), Mass spectroscopy (MS) and other spectroscopic methods as (Z)-3-(but-1″-en-1″-yl)-1-(2ʹ-hydroxyethyl)-4-propylpyridin-1-ium, namely aspongopyridine A, and (E)-3-(but-1″-en-1″-yl)-1-(2ʹ-hydroxyethyl)-4-propylpyridin-1-ium, namely aspongopyridine B, respectively. Besides, the anti-inflammatory, anti-tumor, acetylcholinesterase inhibition and butyrylcholinesterase inhibition activities of the compounds 1 and 2 were evaluated. The results showed that compounds 1 and 2 have no anti-inflammatory, anti-tumor, and butyrylcholinesterase inhibition activities instead of weak acetylcholinesterase inhibition activity.

     

/

返回文章
返回